A new experimental treatment may offer fresh hope for people living with Type 1 Diabetes by helping the body naturally produce insulin again. Researchers studying a stem cell-based therapy called zimislecel found that the treatment restored insulin production in most participants during an early clinical trial, raising the possibility of a future functional cure for the disease.
Type 1 Diabetes develops when the immune system mistakenly destroys the pancreas’s insulin-producing beta cells. Without these cells, patients must rely on lifelong insulin injections or pumps to control blood sugar levels. Zimislecel aims to replace the damaged cells using lab-grown islet cells created from stem cells. Once transplanted into the body, these cells can detect blood sugar levels and release insulin when needed, similar to healthy pancreatic cells.
The phase 1/2 study involved 14 adults with severe Type 1 Diabetes who frequently experienced dangerous episodes of low blood sugar and had little ability to detect when those episodes occurred. Before treatment, none of the participants produced measurable insulin naturally. After receiving the therapy, all participants showed signs of insulin production within one year.
The results were especially encouraging among those who received the full treatment dose. Ten of the 12 participants in that group no longer required insulin injections after 12 months. Researchers also reported major improvements in blood sugar control and a complete absence of severe hypoglycemic episodes after the first three months following treatment.
Although the findings are promising, researchers caution that the therapy is still experimental. Patients currently need immunosuppressive medications to prevent the body from rejecting the transplanted cells, which may increase the risk of infections and other side effects.
Scientists say larger studies are still needed to confirm the treatment’s long-term safety and effectiveness, but the results mark an important advance in the search for better therapies for Type 1 Diabetes.
